Skip to content
Search

Latest Stories

Four new coronavirus cases in UK after cruise ship evacuees test positive

Four further patients in England have tested positive for COVID-19, bringing the total number of cases in the UK to 13.

"The virus was passed on in the Diamond Princess cruise ship and the patients are being transferred from Arrowe Park to specialist NHS infection centres," Chief Medical Officer for England Professor Chris Whitty confirmed on Sunday.


The cruise ship was quarantined on February 5 when a passenger who disembarked in Hong Kong was found infected with the new strain of the coronavirus that has killed 2,345 people in China and 16 elsewhere in the world.

A total 78 Britons had been on board the ship.

A plane carrying dozens of Britons and a few EU nationals who had spent more than two weeks on the ship quarantined off Tokyo landed at Boscombe Down military base in southern England on Saturday.

After landing in the UK, the group soon shifted to Arrowe Park Hospital in the Wirral for a 14 days quarantine.

"The UK has brought home 32 British and European citizens from the Diamond Princess ship," UK Foreign Secretary Dominic Raab said.

"Thanks to our staff and medics on board who supported the flight."

Those who did not make Saturday's flight were either diagnosed with the virus and quarantined in Japan or had been cleared and flew home on their own.

(With AFP inputs)

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less